Actinium Pharmaceuticals (Delaware) (ATNM)'s 30-day implied volatility (IV30) was 84.1% at the close on October 23, 2026, up from 72.7% the day before, against a 52-week range of 42.7% to 260.0%. Its 20-day historical volatility was 93.5%.
Data as of October 23, 2026.